Company Analysis

GlucoTrack, Inc. (GCTK)

OTC: GCTK · Surgical & Medical Instruments & Apparatus · Rutherford, NJ · filing with the SEC since 2010
Grade4.7
◀ Past 3.9● Present 2.4▶ Future 8.5
3 est.

Filings

307 filings since 2017 beside 46 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026
Due nextNon-accelerated filer and smaller reporting company
10-Q Quarterly report for the quarter ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by Nov 14, 2026
10-K Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Mar 31, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. The proxy statement was last filed Aug 10, 2026.

Filings a yearinsider forms included
171616819627964
20192020202120222023202420252026

2026 counts to Nov 13, 2026.

Listing warning from its exchange (8-K item 3.01): 6 times in the last 36 months, the newest Oct 29, 2026.Officer or director change (8-K item 5.02): 7 times in the last 36 months, the newest Sep 18, 2026.Auditor change (8-K item 4.01): 2 times in the last 36 months, the newest Jul 25, 2025.SEC letters: 6 in the last 36 months, the newest Jan 27, 2026.
Insider forms 46

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 12, 2026 SCHEDULE 13G Large holder notice
Oct 29, 2026 8-K item 3.01 Listing warning from its exchange · Current report Oct 28, 2026
Oct 28, 2026 8-K items 5.03, 8.01, 9.01 Charter, bylaw or fiscal-year change; Other event · Current report Oct 23, 2026
Oct 22, 2026 8-K items 1.01, 2.03, 3.02, 7.01, 9.01 Major agreement signed; New debt or obligation taken on; Shares sold without registration; Investor disclosure (Regulation FD) · Current report
Oct 19, 2026 8-K items 1.01, 3.02, 9.01 Major agreement signed; Shares sold without registration · Current report Oct 13, 2026
Oct 14, 2026 S-1/A Listing registration, amended
Oct 13, 2026 PRE 14A Preliminary proxy statement
Oct 13, 2026 425 Merger communication
Oct 13, 2026 8-K/A item 9.01 Financial statements and exhibits · Current report, amended Jul 9, 2026
Sep 28, 2026 8-K items 1.01, 9.01 Major agreement signed · Current report Sep 22, 2026
Sep 24, 2026 424B5 Shelf offering
Sep 24, 2026 8-K items 1.01, 7.01, 9.01 Major agreement signed; Investor disclosure (Regulation FD) · Current report
Sep 23, 2026 425 Merger communication
Sep 23, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Sep 18, 2026 8-K items 5.02, 9.01 Officer or director change · Current report Sep 14, 2026
Sep 18, 2026 S-1 Listing registration
Sep 14, 2026 8-K items 1.01, 5.07, 9.01 Major agreement signed; Shareholder vote · Current report Sep 11, 2026
Sep 11, 2026 8-K items 1.01, 2.03, 3.02, 7.01, 9.01 Major agreement signed; New debt or obligation taken on; Shares sold without registration; Investor disclosure (Regulation FD) · Current report Sep 10, 2026
Sep 9, 2026 8-K items 1.01, 2.03, 3.02 Major agreement signed; New debt or obligation taken on; Shares sold without registration · Current report Sep 4, 2026
Sep 2, 2026 SCHEDULE 13G Large holder notice
Aug 28, 2026 8-K items 5.03, 8.01, 9.01 Charter, bylaw or fiscal-year change; Other event · Current report
Aug 28, 2026 425 Merger communication
Aug 28, 2026 8-K/A items 2.01, 9.01 Purchase or sale of a business completed · Current report, amended Jul 9, 2026
Aug 27, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Aug 21, 2026 DEFA14A Extra proxy material
Aug 19, 2026 8-K item 5.07 Shareholder vote · Current report Aug 18, 2026
Aug 14, 2026 10-Q Quarterly report Jun 30, 2026
Aug 10, 2026 DEF 14A Proxy statement
Aug 10, 2026 8-K items 1.01, 3.02, 9.01 Major agreement signed; Shares sold without registration · Current report Aug 7, 2026
Aug 5, 2026 8-K items 1.01, 2.03, 3.02, 7.01, 9.01 Major agreement signed; New debt or obligation taken on; Shares sold without registration; Investor disclosure (Regulation FD) · Current report Aug 4, 2026
Jul 31, 2026 PRE 14A Preliminary proxy statement
Jul 30, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report Jul 29, 2026
Jul 29, 2026 8-K/A items 1.01, 2.03, 3.02, 9.01 Major agreement signed; New debt or obligation taken on; Shares sold without registration · Current report, amended Jul 22, 2026
Jul 27, 2026 8-K items 1.01, 2.03, 3.02, 9.01 Major agreement signed; New debt or obligation taken on; Shares sold without registration · Current report Jul 22, 2026
Jul 27, 2026 DRS Draft registration, confidential
Jul 17, 2026 ARS Annual report to shareholders Dec 31, 2025
Jul 17, 2026 DEF 14A Proxy statement
Jul 15, 2026 425 Merger communication
Jun 17, 2026 PRE 14A Preliminary proxy statement
40 of 307 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton GCTK · research, not advice